A Phase I Study of CD19 Specific T Cells in CD19 Positive Malignancy

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2013 by Christie Hospital NHS Foundation Trust
Sponsor:
Information provided by (Responsible Party):
Professor Robert Hawkins, Christie Hospital NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT01493453
First received: December 14, 2011
Last updated: November 25, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)